The addition of β-adrenergic antagonists to the treatment regimen for heart failure has validated the neurohormonal hypothesis and provided much-improved outcomes. This benefit had been in ...

The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced ...

Beta-adrenergic blockers function as competitive pharmacologic inhibitors of catecholamine actions that influence a wide number of physiologic and metabolic activities in human beings. It has been ...

Figure 2: Schematic of the desensitization and intracellular trafficking of β-adrenergic receptors. In summary, chronically elevated adrenergic signaling and the subsequent desensitization of ...

Certain areas called adrenergic receptors receive the messages from epinephrine and norepinephrine that tell your body how to respond. Adrenergic drugs also interact with these receptors.

Beta-blockers (also called beta-adrenergic blockers) are drugs that are used to lower blood pressure (among other things). They do this by blocking the effects of the hormones adrenaline and ...

Although beta-adrenergic–receptor antagonists reduce morbidity and mortality in patients with mild-to-moderate chronic heart failure, their effect on survival in patients with more advanced ...

Combining an opioid antagonist such as naloxone with an alpha 2-adrenergic agonist is a feasible approach for managing opioid withdrawal, results of a new Cochrane review suggest. However ...

Ryzumvi is a preservative-free eye drop formulation of phentolamine mesylate, a nonselective alpha-1 and alpha-2 adrenergic antagonist that reduces pupil size. The approval was supported by data ...